Detalles de la búsqueda
1.
Haematology Outcomes Network in Europe (HONEUR)-A collaborative, interdisciplinary platform to harness the potential of real-world data in hematology.
Eur J Haematol
; 109(2): 138-145, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35460296
2.
Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.
Qual Life Res
; 29(2): 369-380, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31655974
3.
Use of Real-World Data Sources for Canadian Drug Pricing and Reimbursement Decisions: Stakeholder Views and Lessons for Other Countries.
Int J Technol Assess Health Care
; 35(3): 181-188, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31133089
4.
Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials.
J Am Acad Dermatol
; 75(6): 1156-1161, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27692498
5.
The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey.
Rheumatology (Oxford)
; 52(12): 2292-301, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24049101
6.
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial.
Ann Rheum Dis
; 70(6): 996-1002, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21415050
7.
Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials.
JAMA Dermatol
; 152(6): 661-9, 2016 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26953848
8.
Patient Characteristics, Health Care Resource Utilization, and Costs Associated with Treatment-Regimen Failure with Biologics in the Treatment of Psoriasis.
J Manag Care Spec Pharm
; 22(4): 396-405, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27023693
9.
Updating the OMERACT filter: implications for patient-reported outcomes.
J Rheumatol
; 41(5): 1011-5, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24584919
10.
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial.
Arthritis Res Ther
; 11(6): R170, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19909548
Resultados
1 -
10
de 10
1
Próxima >
>>